Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Transplantation Proceedings|September 27, 2005
Nosocomial infection in kidney transplant recipients: a retrospective analysis of a single-center experienceM Ferraresso, L BerardinelliPediatric Nephrology (Berlin, Germany)|October 1, 1993
New immunosuppressive agents for pediatric transplantationM Ferraresso, B D KahanInternational Journal of Surgical Investigation|May 9, 2001
One-year experience with a new expanded polytetrafluoroethylene vascular graft for hemodialysisM Ferraresso, L Deotto, F Conte, et al.Transplantation Proceedings|July 15, 2004
Conversion from tacrolimus to cyclosporine for a non-dose-dependent tacrolimus-induced toxicity, a pediatric kidney transplant recipient case reportL Ghio, M Ferraresso, M Giani, et al.Transplantation|April 1, 1993
The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in ratsM Ferraresso, R Ghobrial, S M Stepkowski, et al.Transplantation|October 1, 1992
Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in ratsM E Wang, S M Stepkowski, M Ferraresso, et al.Transplantation Proceedings|December 23, 2018
Intra-operative Postperfusion Micronephrolithotomy for Renal Allograft Lithiasis: A Case ReportE Favi, N Raison, S Zanetti, et al.Annali Italiani Di Chirurgia|March 1, 1991
[Surgical central venous catheterization (SCVC) for total parenteral nutrition (TPN) via the basilic vein]C Finco, M Rossi, G Pittoni, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1994
Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in ratsM Ferraresso, L Tian, R Ghobrial, et al.Transplantation|October 1, 1993
Immunosuppressive effects of defibrotideM Ferraresso, P Rigotti, S M Stepkowski, et al.Pageof 3